Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis

Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis

Abstract Background Statins, metformin, and aspirin have been reported to reduce the incidence of hepatocellular carcinoma (HCC). However, the effect of their perioperative use on survival outcomes of HCC patients following curative liver resection still remains unclear. Method Three hundred and fif...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Elias Khajeh, Ehsan Aminizadeh, Arash Dooghaie Moghadam, Ali Ramouz, Rosa Klotz, Mohammad Golriz, Uta Merle, Christoph Springfeld, De‐Hua Chang, Thomas Longerich, Markus W. Büchler, Arianeb Mehrabi
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Wiley 2023-10-01
Sarja:Cancer Medicine
Aiheet:
aspirin
hepatocellular carcinoma
liver resection
metformin
statin
survival
Linkit:https://doi.org/10.1002/cam4.6569

Internet

https://doi.org/10.1002/cam4.6569

Samankaltaisia teoksia